Articles

• Open Access

  HIV, antiretroviral treatment, hypertension, and stroke in Malawian adultsA case-control study

  Laura A. Benjamin, Elizabeth L. Corbett, Myles D. Connor, Henry Mzinganjira, Sam Kampondeni, Augustine Choko, Mark Hopkins, Hedley C.A. Emsley, Alan Bryer, Brian Faragher, Robert S. Heyderman, Theresa J. Allain, Tom Solomon

  • Abstract
  • Full Text
  • Full Text (PDF)
• Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study

  Ned Sacktor, Richard L. Skolasky, Eric Seaberg, Cynthia Munro, James T. Becker, Eileen Martin, Ann Ragin, Andrew Levine, Eric Miller

  • Abstract
  • Full Text
  • Full Text (PDF)
• Comment: Getting a handle on HAND in the era of cART

  Ronald A. Cohen, Bradford Navia

  • Full Text
  • Full Text (PDF)
• Overdiagnosis of idiopathic intracranial hypertension

  Adeniyi Fisayo, Beau B. Bruce, Nancy J. Newman, Valerie Biousse

  • Abstract
  • Full Text
  • Full Text (PDF)
• Shared genetic susceptibility of vascular-related biomarkers with ischemic and recurrent stroke

  Stephen R. Williams, Fang-Chi Hsu, Keith L. Keene, Wei-Min Chen, Sarah Nelson, Andrew M. Southerland, Ebony B. Madden, Bruce Coull, Stephanie M. Gogarten, Karen L. Furie, Godfrey Dzhivhuho, Joe L. Rowles, Prachi Mehndiratta, Rainer Malik, Josée Dupuis, Honghuang Lin, Sudha Seshadri, Stephen S. Rich, Michèle M. Sale, Bradford B. Worrall

  • Abstract
  • Full Text
  • Full Text (PDF)
• Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type

  Duncan Wilson, Andreas Charidimou, Clare Shakeshaft, Gareth Ambler, Mark White, Hannah Cohen, Tarek Yousry, Rustam Al-Shahi Salman, Gregory Y.H. Lip, Martin M. Brown, Hans Rolf Jäger, David J. Werring

  • Abstract
  • Full Text
  • Full Text (PDF)
• Neurologist ambulatory care, health care utilization, and costs in a large commercial dataset

  John P. Ney, Barbara Johnson, Tom Knabel, Karolina Craft, Joel Kaufman

  • Abstract
  • Full Text
  • Full Text (PDF)

  CME Course
• Open Access

  CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients

  Linda A. Lieberman, Wanyong Zeng, Carol Singh, Wenting Wang, Kevin L. Otipoby, Christine Loh, Tatiana Plavina, Leonid Gorelik, Richard M. Ransohoff, Ellen Cahir-McFarland

  • Abstract
  • Full Text
  • Full Text (PDF)
• Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis

  Elias S. Sotirchos, Pavan Bhargava, Christopher Eckstein, Keith Van Haren, Moira Baynes, Achilles Ntranos, Anne Gocke, Lawrence Steinman, Ellen M. Mowry, Peter A. Calabresi

  • Abstract
  • Full Text
  • Full Text (PDF)

  CME Course
• Mutations in HSPB8 causing a new phenotype of distal myopathy and motor neuropathy

  Roula Ghaoui, Johanna Palmio, Janice Brewer, Monkol Lek, Merrilee Needham, Anni Evilä, Peter Hackman, Per-Harald Jonson, Sini Penttilä, Anna Vihola, Sanna Huovinen, Mikaela Lindfors, Ryan L. Davis, Leigh Waddell, Simran Kaur, Con Yiannikas, Kathryn North, Nigel Clarke, Daniel G. MacArthur, Carolyn M. Sue, Bjarne Udd

  • Abstract
  • Full Text
  • Full Text (PDF)